Compare ELLO & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELLO | NAGE |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.4M | 239.0M |
| IPO Year | 1998 | 2010 |
| Metric | ELLO | NAGE |
|---|---|---|
| Price | $20.00 | $3.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 2.4K | ★ 699.3K |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $35.22 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $16.90 | $2.87 |
| 52 Week High | $30.34 | $10.52 |
| Indicator | ELLO | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 47.58 |
| Support Level | N/A | $2.87 |
| Resistance Level | N/A | $3.61 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 38.41 |
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.